AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05904340 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation
Description: Transcutaneous Electrical Nerve Stimulation (TENS) uses machines to generate electric current, flows through the skin and conducts to the nerves, triggers a chain reaction of nerves through a new stimulus source, and achieves the effect of pain relief. Using different frequencies and intensities will Produce different effects and trigger different physiological mechanisms.
Study NCT04241354 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Leukocyte-poor platelet rich plasma
Description: Platelet rich plasma was prepared using PurePRP Supra Physiologic Protocol A preparation \[EmCyte Corp. Fort Myers FL\].
Study NCT04241354 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Leukocyte-poor platelet rich plasma
Description: Platelet rich plasma was prepared using PurePRP Supra Physiologic Protocol A preparation \[EmCyte Corp. Fort Myers FL\].
Study NCT05341869 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Para-cervical block
Description: Block of inferior hypogastric plexus with local anesthetic
Study NCT05341869 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Para-cervical block
Description: Block of inferior hypogastric plexus with local anesthetic
Study NCT06459063 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Allocetra - Safety run-in phase
Description: Intra-articular injection of Allocetra performed once on Day 1 of the study at different doses.
Study NCT06459063 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intra-articular injection of placebo solution containing all excipients except for the Allocetra cells.
Study NCT06459063 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Allocetra - Randomization phase
Description: Intra-articular injection of selected dose of Allocetra based on the safety run-in, performed on Day 1 of the study.
Study NCT05012241 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Nine Hole Peg Test
Description: At first, each patient will be asked to fill in the questionnaire. Then he/she will be tested by the Nine Hole Peg Test according to the new Czech version of extended manual for this test. Audio recording of verbal instructions will be used.
Study NCT04765774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ekspressive touch
Description: Patients will be divided into three groups. The expressive touch group will touch the patient's hand.
Study NCT04894812 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurodevelopmental technique
Description: 1. st month: postural maintenance; exercises with weight on forearms and hands, in sitting, crawling, semi-kneeling and standing positions with support from therapist.~2. nd month: balance and corrective reactions; using CP ball and tilt board.~3. rd month: ambulation training; appropriate to motor development level (crawling, creeping, walking in a semi-kneeling position and walking between parallel bars).
Study NCT04765774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: The music chosen by the patient will be played in the music group.
Study NCT05477160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (SC)
Description: STAR-0215 will be administered as an SC bolus injection.
Study NCT05477160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (SC)
Description: Placebo will be administered as an SC bolus injection.
Study NCT04894812 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental technique
Description: 1. st month: postural maintenance; exercises with weight on forearms and hands, in sitting, crawling, semi-kneeling and standing positions with support from therapist.~2. nd month: balance and corrective reactions; using CP ball and tilt board.~3. rd month: ambulation training; appropriate to motor development level (crawling, creeping, walking in a semi-kneeling position and walking between parallel bars).
Study NCT04935047 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multilingual Support
Description: Multilingual Support is a classroom intervention, which is designed to be delivered in classes of adult learning of a new language. The intervention involves the use of a language assistant, who is at minimum independent user (B1) in the language to be learned (in this case Norwegian), according to the language proficiency scale of the Common European Framework of Reference (CEFR) for languages, learning, teaching, assessment (Little, 2006). The language assistant will be in the classroom for seven hours a week, collaborating with the teacher in providing language training. In classrooms where participants have different primary languages, the language assistant(s) must cover all languages represented in the classroom.
Study NCT06081673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Penpulimab injection
Description: Penpulimab is a human immunoglobulin G1(IgG1) monoclonal antibody (mAb) directly programmed cell death-1 (PD-1). AK105 can effectively prevent human PD-1 binds to programmed cell death-1 ligand 1(PD-L1) and programmed cell death-1 ligand 2(PD-L2)； 200mg,D1, IV(21 days/cycle).
Study NCT06081673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Cisplatin :75mg/m2, D1, IV(21 days/cycle)
Study NCT06081673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albumin-paclitaxel
Description: albumin-paclitaxel :260mg/m2,IVgtt,D1(21 days/cycle)
Study NCT05477160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STAR-0215 (IV)
Description: STAR-0215 will be administered as an IV bolus injection.
Study NCT05050903 — intervention group
Intervention type: OTHER
Intervention: Rhinovirus infection
Description: Inoculation with rhinovirus-16
Study NCT05044585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote Automated Monitoring System
Description: The subject will be monitored with conventional monitoring devices as well as the MultiSense patch.
Study NCT05477160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (IV)
Description: Placebo will be administered as an IV bolus injection.
Study NCT06088173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Description: Patients in both group will use Kleinert splint. Sessions will start with ice application if there is edema and continue with scar tissue massage. After general hand massage, passive flexion, active extension exercises; tenodesis exercise and passive punch will be performed for the postoperative (postop) first two weeks. In postop 3-4 weeks, four finger sliding exercises, active half fist and NMES (Neuromuscular electrical stimulation) will be performed. In postop 5-6 weeks, blocking exercises, full punch, grappling hooks and small on-digits holding and releasing exercises will be performed additionally.
Study NCT06088173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises and Education
Description: In addition to the same treatment as the patients in the first group, in the first postoperative (postop) two weeks, the gmi will be explained to the patients and lateralization will be started. lateralization refers to right-left discrimination and the patients will be presented with visuals with the help of the noi recognise app and they will have to decide whether the visual is right or left hand. In the postop 3-4th weeks, the motor imagery stage will be started and imagery will be practiced with the help of the same app. In postop 5-6 weeks, mirror therapy will be practiced with the help of a mirror box.
Study NCT05611242 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAS with IV-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added intravenous antiplatelet therapy.
Study NCT05611242 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAS with PO-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added oral antiplatelet therapy.
Study NCT05611242 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MT+CAT with PO-AP
Description: Mechanical Thrombectomy is a treatment for stroke that removes clots that block large blood vessels. Carotid stenting is a procedure that is deployed within the lumen of the carotid artery which treats the narrowing of the carotid artery. With added oral antiplatelet therapy
Study NCT06059300 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis
Description: Screening with Digital Breast Tomosynthesis instead of Digital Mammography, for two screening rounds
Study NCT06090344 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional video format
Description: 6 x 3 minute videos designed in the same format as traditionally found on the internet
Study NCT06090344 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evidence-informed video format
Description: 6 x 3 minute videos designed in the format recommended by advice in the literature
Study NCT05356143 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Rupatadine
Description: Oral single dose 10 mg tablet
Study NCT05130840 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI Brain (unless already done as standard of care within 2 months on enrollment to evaluate for CNS disease) MRI Brain at 2 timepoints 6 months apart (+/- 8 weeks).
Study NCT05130840 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar puncture
Description: LP at 2 timepoints 6 months apart (+/- 8 weeks). LP will be performed to analyze cerebrospinal fluid for: cytology, circulating tumor cells and cell-free DNA.
Study NCT06180603 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Gravity fluid drainage in the radiology department
Description: Patients will be referred to the radiology department. Thoracentesis will be performed according to local guidelines.
Study NCT06180603 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual drainage in the emergency department
Description: Thoracentesis will be performed according to current guidelines in the emergency department. Fluid will manually be drained using a syringe connected to a three-way stopcock. Thoracentesis will be stopped early if:
Study NCT04779099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief 4-session intervention for borderline personality disorder
Description: Intervention consists of weekly 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support. This intervention is detailed in a published manual.
Study NCT04779099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: TAU comprises access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Study NCT06195501 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Flexible Endoscopic Evaluation of Swallowing (FEES) ; Transesophageal Ecocardiography (TEE)
Description: Flexible Endoscopic Evaluation of Swallowing (FEES):~FEES is performed for analysis of swallowing ability according to the same methodology as in the initial trial: one day before a TEE and max. 4 hours after TEE. Before the FEES anticongestive nose drops are applied and the nostrils are anaesthetized by applying a lidocaine gel via cotton sticks. During the FEES examination the participants sit upright and are asked to swallow various consistencies: FEES is aborted in case of aspiration of any of the consistencies during the examination.~Transesophageal Ecocardiography (TEE):~For the TEE anesthesia is applied via intravenous injection of propofol or a combined anesthesia, through intravenous application of propofol and local anesthesia, using lidocaine spray. All patients undergoing a TEE are sober before and at least two to four hours after TEE.
Study NCT05544734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrocodone 5Mg/Acetaminophen 325Mg Tab
Description: 5 mg/325 mg tablet
Study NCT06006884 — intervention group
Intervention type: PROCEDURE
Intervention: Bronchoscopies and Bronchoalveolar Lavages (BALs)
Description: Bronchoscopies use a thin, lighted tube, which enters through the mouth or nose and moves down the throat to the airways to look at the lungs. BALs are done during bronchoscopies to collect samples from the lungs for testing. During this procedure, a saline solution is put through the tube to wash the airways and collect a fluid sample.
Study NCT06006884 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Chest Tomography (CT)
Description: X-ray to create images of the bones and internal organs of the body
Study NCT06006884 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram (ECG)
Description: Measures the electrical activity of the heart by using sticky pads that are placed on your chest and limbs.
Study NCT06006884 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pulmonary function tests (PFTs)
Description: Testing to measure how well lungs are working
Study NCT06006884 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 6 minute walk test (6MWT)
Description: Walking test to see how well the lungs function with exercise over 6 minutes
Study NCT05636332 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 12 lead Electrocardiogram
Description: 12 lead Electrocardiogram
Study NCT05961462 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Patients randomized to the exercise group will be offered aerobic exercise plan containing 12 sessions over 4 weeks (3 times per week).
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: Attend telehealth self-management coaching sessions
Study NCT05683327 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: UltraHA® 75 mg/capsule
Description: Take 2 capsules per day at any time.
Study NCT05683327 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: UltraHA® 40 mg/capsule
Description: Take 2 capsules per day at any time.
Study NCT05683327 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Take 2 capsules per day at any time.
Study NCT06437106 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: A blanket impregnated with the mother's odor
Description: Intervention group 1 consists of premature babies who receive a blanket impregnated with the mother's odor.
Study NCT06437106 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: blanket without mother's smell
Description: Intervention group two consists of preterm infants who receive blanket without mother's odor.
Study NCT06437106 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: The control group includes premature babies who are not subjected to any intervention and receive the usual care.
Study NCT04948229 — intervention group
Intervention type: OTHER
Intervention: Blood serum samples
Description: Blood serum samples will be taken.
Study NCT05089695 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Noninvasive respiratory support
Description: Treatment of acute hypoxemic respiratory failure
Study NCT04779099 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: TAU comprises access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Study NCT05862688 — intervention group
Intervention type: OTHER
Intervention: antimicrobial therapy
Description: antimicrobial therapy
Study NCT05089695 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Noninvasive respiratory support
Description: Treatment of acute hypoxemic respiratory failure
Study NCT06118567 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: Nitrous oxide gas.
Study NCT05544734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen 1000mg
Description: 1000 mg tablet
Study NCT06118567 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Room Air
Description: Room Air
Study NCT04846348 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Topical preparation of sodium cromolyn 5%, diphenhydramine 1% and trolamine salicylate 10% in emollient cream base.
Description: Combination of ingredients includes 2 agents which target mast cell mediators and one agent which globally reduces mast cell degranulation combined in an emollient cream base (Vanicream).components: Vanicream: Over the counter emollient cream Diphenhydramine Antihistamine Trolamine salicylate Prostaglandin inhibitor, antiinflammatory Cromolyn Sodium Mast cell degranulation inhibitor
Study NCT05544734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen 400 mg
Description: 400 mg tablet
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Attend telehealth self-management coaching sessions
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard of care
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06524973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inrweview
Description: Ancillary studies
Study NCT05685030 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: product vehicle (sunflower oil)
Study NCT05685030 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri CCT 7862
Description: Limosilactobacillus reuteri CCT 7862 - 1 x 10e9 UFC/ day.
Study NCT05685030 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863
Description: Bifidobacterium lactis CCT 7858 + Lactobacillus rhamnosus CCT 7863 - 1 x 10e9 UFC/ day
Study NCT05340114 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CEREBO®
Description: Near-infrared based point-of-care portable intracranial hematoma detector
Study NCT06335576 — intervention group
Intervention type: OTHER
Intervention: This study is a single-arm and observational study with no intervention.
Description: This study is a single-arm and observational study with no intervention.
Study NCT06020963 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Intensity Shockwave Therapy (LiSWT)
Description: Low Intensity Shockwave Therapy (LiSWT) has been used for many years. Its mechanism is to use shock wave energy to promote angiogenesis to achieve the functions of tissue repair and cell regeneration.
Study NCT06020963 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamsulosin
Description: Tamsulosin is a selective alpha-1 blocker, its main function is to relax the smooth muscles of the base of the prostate, urethra, and bladder, and improve lower urinary tract symptoms.
Study NCT05639777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group
Description: That will receive intranasal dexmedetomidine (1.5mcg/kg)
Study NCT05639777 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control group
Description: That will receive the same volume of 2 ml of intranasal normal saline
Study NCT05355623 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal Repair
Description: Vaginal Repair will be done either by application of sterilized (gamma irradiated) amniotic membrane or by Classical repair
Study NCT04982445 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CABENUVA
Description: CABENUVA will be administered IM at infusion centers/ASAs
Study NCT06078787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib 150 MG
Description: Olaparib should be dosed 2 x 150 mg tablets (300 BID)
Study NCT04686318 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarkers for acute pyelonephritis
Description: Blood samples will be collected by a medical laboratory technologist and transferred to the local laboratory for analysis of CRP, PCT and suPAR. Laboratory staff will be blinded to participant diagnosis and outcome. CRP and PCT results will be available to the treating physician, but the suPAR result will not be available.~* Diagnostic test of CRP. CRP will be measured using an immunoturbidimetric assay (Tina-quant®, Roche) on Roche/Hitachi Cobas© systems.~* Diagnostic test of PCT: Plasma PCT will be quantified by an automated sandwich immunoassay ECLIA (Elecsys®, BRAHMS PCT-analyses) on Cobas© within two hours from collection according to standard procedure.~* Diagnostic test of suPAR: Plasma suPAR will be quantified by using the commercial available suPARnostic© Tubilatex assay reagents (ViroGates, Denmark) on Cobas© as previously validated (35). Separated plasma is kept refrigerated and analysed for suPAR within 48 hours after collection.
Study NCT04869904 — intervention group
Intervention type: PROCEDURE
Intervention: dental and plaque sampling
Description: sampling of dental plaque and saliva during the treatment
Study NCT05511831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketotifen Fumarate
Description: Ketotifen treatment for 3 months, 1 mg each time, 1-2 times a day according to the patient's tolerance